HESG Health Sciences Group Inc. featured news, full reports, and detailed charts
Health Sciences Group Inc. (HESG/HESG.PK) Wrap Up:
Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. It primarily offers Shugr, a zero-calorie sugar substitute that tastes and bakes like cane sugar; and Sequesterol Advance Cardio Formula, a proprietary blend of clinically studied ingredients for the maintenance of cardiovascular health and a free-flowing circulatory system. The company also offers Aplevia, an antioxidant derived from apple peels; and Edible Sponges, an open-cell hydrocolloid product. It sells its products primarily through mass market retailers, such as mass merchandisers, drug stores, supermarkets, and disc...Health Sciences Group, Inc. (HESG:OTC)
|
Market Cap
90.1K
|
Total Revenue
69.3K
|
|
|
EBITDA
4.5M
|
DILUTED EPS TTM
-0.13
|
|
|
P/E
--
|
P/S
0.9x
|
|
|
Return On Asset
-72.97
|
Return On Equity
153.15
|
|
| K = Thousands M = Millions B = Billions | ||
related news
Plus Wall Street analyst opinions on Nu Skin, Health Sciences, Herbalife, and Ultra Clean
Plus Wall Street analyst opinions on Nu Skin, Health Sciences, Herbalife, and Ultra Clean
related news
HESG Top Compensated Officers
Executives, Board Directors
Key developments for Health Sciences Group, Inc. (HESG)
Health Sciences Group, Inc. would like to announce that in addition to finalizing a consulting agreement with Medical Marijuana, Inc. in its pursuit to enter the Medical Marijuana business it has also contacted several law firms in California and Colorado for purposes of licensing requirements for dispensaries. Thomas Gaffney, Health Sciences CEO, states, "That in addition to entering into a consulting agreement with Medical Marijuana, Inc. we have contacted several law firms in Colorado and California pertaining to medical marijuana laws -- basically the requirements of licensing. We have all intentions of entering the world of medical marijuana in the near future. We have also been in contact with some operating dispensaries about possible acquisitions."
Health Sciences Group, Inc. announced that its CEO Thomas Gaffney has finalized a consulting agreement with Medical Marijuana, Inc. on a comprehensive agreement to advise on compliance issues with any state, local and city medical marijuana issues concerning the operations of dispensaries in California.
Health Sciences Group Inc. announced the appointment of Dr. Fred Aserati as vice president of business development to explore acquisitions of Medical Marijuana Companies and Partnerships. Aserati has an extensive background in studying the government's policy on the growing and distribution of medical Cannabis/Marijuana.
HESG Competitors
| Company | Last | Change | |
| No competitor information is available for HESG. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | HESG | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.9x |
Not meaningful
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
HESG |
||
HESG transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
